H.I.G. Europe, the European arm of global private equity firm H.I.G. Capital, has acquired a controlling stake in Santa Lucia Pharma Apps (SLPA), an Italian provider of advanced services to hospitals.
SPLA offers integrated turn-key solutions to hospitals, enabling them to track and manage unit dose drugs and medical devices. SPLA solutions provides a comprehensive offering including proprietary software, patented robotic technologies, specialist support services and enabled drug and medical devices management. The company’s technology seeks to decrease the errors in its customers’ therapy management and related waste, resulting in material savings for hospitals on reduced drug spending and clinical risk.
Piacenza, Italy-based SLPA currently delivers medicines to over 10,000 beds in 25 Italian hospitals. With the new investment from H.I.G., SLPA Chairman Sergio Giglio says the company will accelerate its expansion strategy in Europe and internationally.
Miami-based H.I.G., which manages more than 20 billion euros ($22.8 billion) of equity capital and focuses on small and mid-sized companies, will provide SLPA with the resources, experience and network to support the internationalization process of the company, says Managing Director at H.I.G. Italy, Raffaele Legnani.
Founded in 1993, H.I.G. has invested in and managed over 200 companies around the world. Its current portfolio includes more than 100 companies with combined annual sales greater than 28 billion euros ($32 billion).
